Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 226,341,792 papers from all fields of science
Search
Sign In
Create Free Account
thrombin activity
OBSOLETE. Catalysis of the preferential cleavage of Arg-Gly; activates fibrinogen to fibrin and releases fibrinopeptide A and B. [EC:3.4.21.5]
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Thrombin
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
[Effects of harvest and different processing methods on anti-thrombin activity of Poecilobdella manillensis].
Ling Guo
,
Bo-xing Cheng
,
+7 authors
Daoxin Dai
Zhongguo Zhong yao za zhi = Zhongguo zhongyao…
2016
Corpus ID: 21683546
The effects of harvest and different processing methods on the anti-thrombin activity of Poecilobdella manillensis were…
Expand
2014
2014
GpIbα Interacts Exclusively with Exosite II of Thrombin☆
B. C. Lechtenberg
,
S. Freund
,
J. Huntington
Journal of Molecular Biology
2014
Corpus ID: 13919444
2009
2009
Regulation of Thrombin Activity with a Bifunctional Aptamer and Hemin: Development of a New Anticoagulant and Antidote Pair
Jing Wang
,
Yabing Cao
,
Guifang Chen
,
Genxi Li
ChemBioChem
2009
Corpus ID: 28824871
Thrombin is able to induce thrombosis and tumor angiogenesis, and the study of thrombin inhibitors has recently received more…
Expand
2007
2007
Both ADP and Thrombin Regulate Arteriolar Thrombus Stabilization and Embolization, but Are Not Involved in Initial Hemostasis as Induced by Micropuncture
M. V. van Gestel
,
S. Reitsma
,
+8 authors
M. Egbrink
Microcirculation
2007
Corpus ID: 23899463
ABSTRACT
2005
2005
Mapping the interaction of bradykinin 1–5 with the exodomain of human protease activated receptor 4
M. Nieman
,
E. Pagán-Ramos
,
M. Warnock
,
Y. Krijanovski
,
A. Hasan
,
A. Schmaier
FEBS Letters
2005
Corpus ID: 24080064
1999
1999
Differential Inhibition of Thrombin Activity and Thrombin Generation by a Synthetic Direct Thrombin Inhibitor (Napsagatran, Ro 46-6240) and Unfractionated Heparin in Patients with Deep Vein…
H. Bounameaux
,
H. Ehringer
,
+5 authors
T. Tschopp
Thrombosis and Haemostasis
1999
Corpus ID: 38572434
Summary Background: Direct thrombin inhibitors belong to a new class of antithrombotic drugs whose effects on blood coagulation…
Expand
Highly Cited
1996
Highly Cited
1996
Association of heparin-resistant thrombin activity with acute ischemic complications of coronary interventions.
L. Oltrona
,
P. Eisenberg
,
J. Lasala
,
D. Sewall
,
M. Shelton
,
K. Winters
Circulation
1996
Corpus ID: 26467350
BACKGROUND Acute thrombosis is thought to contribute to abrupt coronary occlusion during percutaneous coronary revascularization…
Expand
1992
1992
A non‐occlusive model of arterial thrombus formation in the rat and its modification by inhibitors of platelet function, or thrombin activity
K. Butler
,
J. Ambler
,
S. Dolan
,
J. Giddings
,
M. Talbot
,
R. Wallis
Blood Coagulation and Fibrinolysis
1992
Corpus ID: 25402329
A technically simple model of arterial thrombosis in the rat, induced by a crush injury to the dorsal aorta is described. The…
Expand
1991
1991
In vitro non-thrombogenicity of a thrombin-substrate-immobilized polymer surface by the inhibition of thrombin activity.
Y. Ito
,
L. S. Liu
,
Y. Imanishi
Journal of Biomaterials Science. Polymer Edition
1991
Corpus ID: 12083504
Derivatives of thrombin substrate were synthesized and immobilized on a poly(acrylic acid)-grafted polyurethane film. The…
Expand
Highly Cited
1989
Highly Cited
1989
Anticoagulant Effects of Heparin in Neonatal Plasma'
Barbara Schmidt
,
F. A. Ofosu
,
Lesley Mitchell
,
L. Brooker
,
Maureen Andrew
Pediatric Research
1989
Corpus ID: 25808869
ABSTRACT: Available data on the anticoagulant effects of heparin in neonatal plasma are scarce and conflicting: relative to adult…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE